Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…
DelveInsight's "Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023-United States" Report provides an overview of the disease and market size of the CMV for United States. It also includes historical and forecasted epidemiological data for the CMV Prevalent, Diagnosed and Treatable Cases, CMV Patients among Transplants, Infants Patients at High Risk of CMV and HIV Patients at High Risk of CMV from 2013-2023.
As per DelveInsight's estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023. The US market size of Cytomegalovirus (CMV) infection shall reach to USD 609.88 Million by the end of 2023. The market size for Prophylaxis is expected to grow at a CAGR of 3.71% from 2013-2023, while the sales for the therapeutic shall increase at a CAGR of 3.55% from the year 2013-2023.As per DelveInsight's estimation, the US Prophylaxis market is relatively higher than the therapeutic market.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs.
- The Report also covers the detailed historical and forecasted epidemiological data covering United States from 2013-2023.
- It also provides Market size of Cytomegalovirus (CMV) infection for United States from 2013 and forecasted Market size to 2023.